American Journal of Cardiology
Volume 104, Issue 2 , Pages 175-181, 15 July 2009

Predictors of Early Discontinuation of Evidence-Based Medicine After Acute Coronary Syndrome

  • Chiara Melloni, MD, MHS

      Affiliations

    • Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina
    • Corresponding Author InformationCorresponding author: Tel: 919-668-8646; fax: 919-668-7057
    • ,
  • Karen P. Alexander, MD

      Affiliations

    • Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina
    • ,
  • Fang-Shu Ou, MS

      Affiliations

    • Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina
    • ,
  • Nancy M. Allen LaPointe, PharmD

      Affiliations

    • Division of Clinical Pharmacology, Duke University Medical Center, Durham, North Carolina
    • ,
  • Matthew T. Roe, MD, MHS

      Affiliations

    • Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina
    • ,
  • L. Kristin Newby, MD, MHS

      Affiliations

    • Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina
    • ,
  • Khaula Baloch, BA

      Affiliations

    • Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina
    • ,
  • P. Michael Ho, MD, PhD

      Affiliations

    • Division of Cardiology, Denver VA Medical Center and University of Colorado Health Sciences Center, Denver, Colorado
    • ,
  • John S. Rumsfeld, MD, PhD

      Affiliations

    • Division of Cardiology, Denver VA Medical Center and University of Colorado Health Sciences Center, Denver, Colorado
    • ,
  • Eric D. Peterson, MD, MPH

      Affiliations

    • Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina

Received 22 January 2009; received in revised form 8 March 2009; accepted 8 March 2009. published online 04 June 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 MAINTAIN is funded by Bristol-Myers Squibb/Sanofi-Aventis Pharmaceuticals partnership and by Merck Schering-Plough Pharmaceutical.

PII: S0002-9149(09)00726-7

doi:10.1016/j.amjcard.2009.03.013

American Journal of Cardiology
Volume 104, Issue 2 , Pages 175-181, 15 July 2009

Article Tools

* Image Usage & Resolution